Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-methyl-2,4(1h,3h)-pyrimidinedione,
2. 1-(2-deoxy-2-fluoro-beta-l-arabinofuranosyl)-5-methyl-2,4(1h,3h)-pyrimidinedione
3. 1-(2-fluoro-2-deoxy-beta-arabinofuranosyl)thymine
4. 1-(2-fluoro-2-deoxy-beta-d-arabinofuranosyl)thymine
5. 1-(2-fluoro-5-methyl-beta,l-arabinofuranosyl)uracil
6. 1-(2-fluoro-beta-l-arabinofuranosyl)thymine
7. 2'-deoxy-2'-fluoroarabinofuranosylthymine
8. 2'-fluoro-5-methyl-1-beta-d-arabinofuranosyluracil
9. 2'-fluoro-5-methylarabinosyluracil
10. 2'-fluoro-5-methylarabinosyluracil, 2-(14)c-labeled
11. 5-methyl-2'-fluoroarauracil
12. Clevudine
13. D-fmau
14. Fmau
15. L-fmau
1. Clevudine
2. 163252-36-6
3. L-fmau
4. Levovir
5. Clevudine (levovir)
6. In51mvp5f1
7. 1-(2-deoxy-2-fluoro-beta-l-arabinofuranosyl)thymine
8. 2'-fluoro-5-methyl-beta-l-arabinofuranosyluracil
9. Clevudine (usan)
10. Clevudine [usan]
11. 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-.beta.-l-arabinofuranosyl)-5-methyl-
12. Clevudine [usan:inn]
13. Unii-in51mvp5f1
14. Revovir
15. Mfcd00935785
16. Clevudine (form 2)
17. 1-(2-deoxy-2-fluoro-ss-l-arabinofuranosyl)-5-methyl-2,4-(1h,3h)-pyrimidinedione
18. Clevudine [inn]
19. Clevudine [mi]
20. Clevudine [who-dd]
21. 1-[(2s,3r,4s,5s)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
22. Mls006011168
23. Schembl233494
24. Chembl458875
25. Zinc1484
26. Dtxsid2057659
27. Chebi:135964
28. S3001
29. Akos015951181
30. Ac-1177
31. Ccg-267053
32. Db06683
33. Ds-3428
34. 1-(2-deoxy-2-fluoro-beta-l-arabinofuranosyl)-5-methyl-2,4(1h,3h)-pyrimidinedione
35. Ncgc00371259-05
36. 1-[(2s,3r,4s,5s)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
37. Am807730
38. Smr004702937
39. D03537
40. A855725
41. 2'-fluoro-5-methyl-.beta.-l-arabinofuranosyluracil
42. Q1100864
43. 1-(2-deoxy-2-fluoro-beta-l-arabinofuranosyl) Thymine
44. 1-(2-deoxy-2-fluoro-.beta.-l-arabinofuranosyl)thymine
45. 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-
46. A-l-arabinofuranosyl)-5-methyl-
47. 1-[(2s,3r,4s,5s)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-4-hydroxy-5-methyl-pyrimidin-2-one
Molecular Weight | 260.22 g/mol |
---|---|
Molecular Formula | C10H13FN2O5 |
XLogP3 | -0.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 260.08084968 g/mol |
Monoisotopic Mass | 260.08084968 g/mol |
Topological Polar Surface Area | 99.1 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 413 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in hepatitis (viral, B).
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
J - Antiinfectives for systemic use
J05 - Antivirals for systemic use
J05A - Direct acting antivirals
J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF12 - Clevudine
ABOUT THIS PAGE
A Clevudine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clevudine, including repackagers and relabelers. The FDA regulates Clevudine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clevudine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clevudine supplier is an individual or a company that provides Clevudine active pharmaceutical ingredient (API) or Clevudine finished formulations upon request. The Clevudine suppliers may include Clevudine API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clevudine Drug Master File in Korea (Clevudine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clevudine. The MFDS reviews the Clevudine KDMF as part of the drug registration process and uses the information provided in the Clevudine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clevudine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clevudine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clevudine suppliers with KDMF on PharmaCompass.
Clevudine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clevudine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clevudine GMP manufacturer or Clevudine GMP API supplier for your needs.
A Clevudine CoA (Certificate of Analysis) is a formal document that attests to Clevudine's compliance with Clevudine specifications and serves as a tool for batch-level quality control.
Clevudine CoA mostly includes findings from lab analyses of a specific batch. For each Clevudine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clevudine may be tested according to a variety of international standards, such as European Pharmacopoeia (Clevudine EP), Clevudine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clevudine USP).
LOOKING FOR A SUPPLIER?